Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination

JAMA Oncol. 2021 Sep 1;7(9):1395-1397. doi: 10.1001/jamaoncol.2021.3127.

Abstract

This case series examines the incidence, timing, and characteristics of mammographic axillary adenopathy following COVID-19 vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Axilla / diagnostic imaging*
  • Breast / diagnostic imaging*
  • Breast Neoplasms / diagnosis
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / adverse effects*
  • Female
  • Humans
  • Incidence
  • Lymphadenopathy / diagnostic imaging
  • Lymphadenopathy / etiology*
  • Mammography
  • Middle Aged
  • SARS-CoV-2 / immunology
  • Ultrasonography

Substances

  • COVID-19 Vaccines